Preprints.org
Glucagon-Like Peptide-1 Receptor Agonists in Obesity: Evidence for Dose Reduction and Durable Weight Loss Maintenance
Preprint: reviewInterventions
The paper
Preprints.org, 9 Oct 2026, Preprint, not peer-reviewed
Related
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes